I've read them. I know what they say. Do you?
I'll tell you what. I live in Nebraska. If you can find a location that is currently providing to the public the FDA approved Comirnaty vaccines in the state, I'll write a $100 check to the 501c3 charity of your choice (with very few exceptions).
This is taken directly from the FDA's FAQ page:
A
: The Pfizer-BioNTech COVID-19 Vaccine has the same formulation as the FDA-approved Comirnaty COVID-19 vaccine and can be used interchangeably to provide the COVID-19 vaccination series without presenting any safety or effectiveness concerns. The products are legally distinct with certain differences that do not impact safety or effectiveness.
Other items of note from the FAQ page, along with the BLA Approval letter:
A
: It is not known if the vaccine protects against asymptomatic SARS-CoV-2 infection.
A: Most vaccines that protect from viral illnesses also reduce transmission of the virus that causes the disease by those who are vaccinated. While it is hoped this will be the case, the scientific community does not yet know if the Pfizer-BioNTech COVID-19 Vaccine will reduce such transmission.
A. Post-authorization safety surveillance data pertaining to myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) demonstrate increased risks of myocarditis and pericarditis, particularly within 7 days following the second dose of the Pfizer-BioNTech COVID-19 Vaccine, with the risk being higher in males under 40 years of age than in females or older males. The observed risk is highest in males 12 through 17 years of age.
A: While there have been no specific studies in these groups, there is no contraindication to receipt of the vaccine for pregnant or breastfeeding women. Pregnant or breastfeeding women should discuss potential benefits and risks of vaccination with their healthcare provider.
And this, which comes DIRECTLY FROM the BLA Approval letter:
We have determined that an analysis of spontaneous postmarketing adverse events reported under section 505(k)(1) of the FDCA will not be sufficient to assess
known serious risks of myocarditis and pericarditis and identify an unexpected serious risk of subclinical myocarditis.
Bottom line: You know not of what you speak. The risk of the jab to healthy sub-40 males is especially pronounced, especially compared to the virus itself. And for kids, it's asinine to require them to be vaccinated, and potentially dangerous. Read the BLA Approval letter for yourself, and how many tests that are typically required before Approval have been deferred, and when we can expect the data.
There's strong and compelling evidence it works to reduce or eliminate symptoms in the infected. If you're at high risk, it may very well be advisable for you to take it. There's scant evidence it reduces transmission. And those under 40 don't need it, unless they have other risk factors. Facts.